Literature DB >> 21261795

Histidine acts as a co-germinant with glycine and taurocholate for Clostridium difficile spores.

L J Wheeldon1, T Worthington, P A Lambert.   

Abstract

AIMS: It is well established that the bile salt sodium taurocholate acts as a germinant for Clostridium difficile spores and the amino acid glycine acts as a co-germinant. The aim of this study was to determine whether any other amino acids act as co-germinants. METHODS AND
RESULTS: Clostridium difficile spore suspensions were exposed to different germinant solutions comprising taurocholate, glycine and an additional amino acid for 1 h before heating shocking (to kill germinating cells) or chilling on ice. Samples were then re-germinated and cultured to recover remaining viable cells. Only five amino acids out of the 19 common amino acids tested (valine, aspartic acid, arginine, histidine and serine) demonstrated co-germination activity with taurocholate and glycine. Of these, only histidine produced high levels of germination (97·9-99·9%) consistently in four strains of Cl. difficile spores. Some variation in the level of germination produced was observed between different PCR ribotypes, and the optimum concentration of amino acids with taurocholate for the germination of Cl. difficile NCTC 11204 spores was 10-100 mmol l-1.
CONCLUSIONS: Histidine was found to be a co-germinant for Cl. difficile spores when combined with glycine and taurocholate.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21261795     DOI: 10.1111/j.1365-2672.2011.04953.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  14 in total

Review 1.  Vaccines against Clostridium difficile.

Authors:  Rosanna Leuzzi; Roberto Adamo; Maria Scarselli
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

Review 2.  Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection.

Authors:  Casey M Theriot; Vincent B Young
Journal:  Gut Microbes       Date:  2013-12-11

3.  Variation in germination of Clostridium difficile clinical isolates correlates to disease severity.

Authors:  Paul E Carlson; Alyssa M Kaiser; Sarah A McColm; Jessica M Bauer; Vincent B Young; David M Aronoff; Philip C Hanna
Journal:  Anaerobe       Date:  2015-02-11       Impact factor: 3.331

Review 4.  Surviving Between Hosts: Sporulation and Transmission.

Authors:  Michelle C Swick; Theresa M Koehler; Adam Driks
Journal:  Microbiol Spectr       Date:  2016-08

Review 5.  Clostridium difficile spore biology: sporulation, germination, and spore structural proteins.

Authors:  Daniel Paredes-Sabja; Aimee Shen; Joseph A Sorg
Journal:  Trends Microbiol       Date:  2014-05-07       Impact factor: 17.079

Review 6.  Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection.

Authors:  Caná L Ross; Jennifer K Spinler; Tor C Savidge
Journal:  Anaerobe       Date:  2016-05-12       Impact factor: 3.331

Review 7.  Updates to Clostridium difficile Spore Germination.

Authors:  Travis J Kochan; Matthew H Foley; Michelle S Shoshiev; Madeline J Somers; Paul E Carlson; Philip C Hanna
Journal:  J Bacteriol       Date:  2018-07-25       Impact factor: 3.490

8.  Reexamining the Germination Phenotypes of Several Clostridium difficile Strains Suggests Another Role for the CspC Germinant Receptor.

Authors:  Disha Bhattacharjee; Michael B Francis; Xicheng Ding; Kathleen N McAllister; Ritu Shrestha; Joseph A Sorg
Journal:  J Bacteriol       Date:  2015-12-14       Impact factor: 3.490

9.  Clostridium difficile spore-macrophage interactions: spore survival.

Authors:  Daniel Paredes-Sabja; Glenda Cofre-Araneda; Christian Brito-Silva; Marjorie Pizarro-Guajardo; Mahfuzur R Sarker
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

10.  Transcriptional analysis of temporal gene expression in germinating Clostridium difficile 630 endospores.

Authors:  Marcin Dembek; Richard A Stabler; Adam A Witney; Brendan W Wren; Neil F Fairweather
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.